Company Profiles

driven by the PitchBook Platform

AccuraGen

Description

Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's liquid biopsy technology circulates DNA from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer-mutation detection services.

2013

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$40M

Latest Deal Amount

$46.9M

Total Amount Raised

Description

Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's liquid biopsy technology circulates DNA from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer-mutation detection services.

Website:

www.accuragen.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Biotechnology

Primary Office

1445 Adams Drive Suite 1015 Menlo Park, CA 94025United States +1 (650) 618-5028
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AccuraGen's full profile, request a free trial.

    AccuraGen Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AccuraGen Investors (9)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Decheng CapitalVenture CapitalMinority000 0000000 0000
    Denlux CapitalOtherMinority000 0000000 0000
    DT Capital PartnersPE/BuyoutMinority000 0000000 0000
    Junson CapitalFamily OfficeMinority000 0000000 0000
    Nan Fung CapitalOtherMinority000 0000000 0000
    Decheng Capital Venture Capital
    Denlux Capital Other
    DT Capital Partners PE/Buyout
    Junson Capital Family Office
    Nan Fung Capital Other

    AccuraGen Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Kang Ying Ph.DCo-Founder, Chief Executive Officer and Chairman
    Shengrong Lin Ph.DCo-Founder, President, Chief Technology Officer and Board Member
    Grace Zhao Ph.DCo-Founder and Director of Research
    Zhaohui SunCo-Founder & CIO
    Paul Tang Ph.DCo-Founder & Vice President of Business Development & Product
    Kang Ying Ph.D Co-Founder, Chief Executive Officer and Chairman
    Shengrong Lin Ph.D Co-Founder, President, Chief Technology Officer and Board Member
    Grace Zhao Ph.D Co-Founder and Director of Research
    Zhaohui Sun Co-Founder & CIO
    Paul Tang Ph.D Co-Founder & Vice President of Business Development & Product

    AccuraGen Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Dan Zabrowski Ph.DDecheng CapitalVenture Partner000 0000
    Kevin LiuJunson CapitalChief Executive Officer000 0000
    Min Cui Ph.DDecheng CapitalFounding Partner & Managing Director000 0000
    Wei XuDenlux CapitalExecutive Partner000 0000
    Dan Zabrowski Ph.D Venture Partner Decheng Capital
    Kevin Liu Chief Executive Officer Junson Capital
    Min Cui Ph.D Founding Partner & Managing Director Decheng Capital
    Wei Xu Executive Partner Denlux Capital
    Request full access to PitchBook